Evaluation of Roche diagnostics ONLINE® DAT II, a new generation of for the detection of drugs of abuse

Journal of Analytical Toxicology

Volumn 28, Issue 7, 2004, Pages 593-598

  Feldman, M ^a   Kuntz, D ^a   Botelho, K ^a   Ananias, D C ^b   Gnezda, M ^b   Hoch, D K ^b   Jordan, S L ^b   Rashid, S ^b   Zhao, Y ^b  

^a Northwest Bioanalytical   (United States)

^b Roche Diagnostics Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOYLECGONINE; METHADONE; OPIATE; TETRAHYDROCANNABINOL;

ANALYZER; ARTICLE; CONTROLLED STUDY; DRUG URINE LEVEL; GAS CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; MASS SPECTROMETRY; QUALITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY;

CANNABIS;

EID: 4744350441     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/28.7.593     Document Type: Article

References (31)

1. D.A. Armbruster, R.H. Schwarzhoff, B.L. Pierce, and E.C. Hubster. Method comparison of EMIT II and OnLine with RIA for drug screening. J. Forensic Sci. 38:1326-1341 (1993).
2. D.A. Armbruster, R.H. Schwarzhoff, B.L. Pierce, E.C. Hubster, and M.K. Liserio. Enzyme immunoassay, kinetic microparticle immunoassay, radioimmunoassay and fluorescence polarization immunoassay compared for drugs-of-abuse screening. Clin. Chem. 39(10): 2137-2146 (1993).
3. A.J. McNally, K. Goc-Szkutnicka, Z. Li, I. Pilcher, S. Polakowski, and S.J. Salamone. An OnLine immunoassay for LSD: comparison with GC-MS and the Abuscreen RIA. J. Anal. Toxicol. 20(6): 404-408 (1996).
4. Z. Li, K. Goc-Szkutnicka, A.J. McNally, I. Pilcher, S. Polakowski, S. Vitone, R. Wu, and S.J. Salamone. Synthesis of new D-propoxyphene derivatives and the development of a microparticle-based immunoassay for the detection of propoxyphene and norpropoxyphene. Bioconjug. Chem. 8(6): 896-905 (1997).
5. R. Wu, A.J. McNally, I.A. Pilcher, and S.J. Salamone. New synthesis and characterization of (+)-lysergic acid diethylamide (LSD) derivatives and the development of a microparticle-based immunoassay for the detection of LSD and its metabolites. Bioconjug. Chem. 8(3): 385-390 (1997).
6. I.D. Morrison and S. Ross. Colloidal Dispersions. John Wiley and Sons, Inc., New York, NY, 2002, pp 1-14.
7. Roche Diagnostics Corp. ONLINE® Cocaine II, 2003-1. Package insert. Roche Diagnostics Corp., Indianapolis, IN.
8. Roche Diagnostics Corp. ONLINE® Methadone II, 2003-1. Package insert. Roche Diagnostics Corp., Indianapolis, IN.
9. Roche Diagnostics Corp. ONLINE® Opiates-Semiquantitative. Package insert. Roche Diagnostics Corp., Indianapolis, IN, Sept. 1998.
10. Roche Diagnostics Corp. ONLINE® Cannabinoids II. Package insert. Roche Diagnostics Corp., Indianapolis, IN, 2003.
11. Roche Diagnostic Systems. Online 100-Test Kit for Cocaine Metabolite. Package insert. Roche Diagnostics Corp., Indianapolis, IN, Jan. 1991.
12. Roche Diagnostic Systems. Online 100-Test Kit for Methadone. Package insert. Roche Diagnostic Corp., Indianapolis, IN, May 1993.
13. Roche Diagnostic Systems. Online 100-Test Kit for Opiates. Package insert. Roche Diagnostic Corp., Indianapolis, IN, Jan. 1991.
14. Roche Diagnostic Systems. Online 100-Test Kit for Cannabinoids. Package insert. Roche Diagnostic Corp., Indianapolis, IN, Sept. 1992.
15. D.A. Armbruster. LOD/LOQ: comparison of the empirical and statistical methods exemplified with GC-MS assays of abused drugs. Clin. Chem. 40(7): 1233-1239 (1994).
16. Dade Behring. EMIT II Plus Opiate Assay. Package insert. Dade Behring, Deerfield, IL, Oct. 1991.
17. Dade Behring. EMIT II Cocaine Metabolite Assay. Package insert. Dade Behring, Deerfield, IL, May 1992.
18. Dade Behring. EMIT II Methadone Assay. Package insert. Dade Behring, Deerfield, IL, March 1992.
19. Dade Behring. EMIT II Plus Cannabinoid Assay. Package insert. Dade Behring, Deerfield, IL, June 2001.
20. Microgenics. CEDIA® DAU Opiate-Semiquantitative. Package insert. Microgenics, Fremont, CA, 1997.
21. Microgenics. CEDIA® DAU Cocaine-Semiquantitative. Package insert. Microgenics, Fremont, CA, 1997.
22. Microgenics. CEDIA® DAU Methadone-Semiquantitative. Package insert. Microgenics, Fremont, CA, 1997.
23. Microgenics. CEDIA® DAU Multi-Level THC-Semiquantitative. Package insert. Microgenics, Fremont, CA, 1997.
24. A.H.B. Wu, B. Bristol, K. Sexton, G. Cassela-McLane, V. Holtman, and D.W. Hill. Adulteration of urine by "Urine Luck". Clin. Chem. 45(7): 1051-1057 (1999).
25. A.H.B. Wu, E. Forte, G. Cassela-McLane, K. Sun, G. Hemphill, R. Foery, and H. Schanzenbach. CEDIA for screening drugs of abuse in urine and the effect of adulterants. J. Forensic Sci. 40: 614-618 (1995).
26. S. George and R.A. Braithwaite. The effect of glutaraldehyde adulteration of urine specimens on Syva EMIT II drugs-of-abuse assays. J. Anal. Toxicol. 20:195-196 (1996).
27. C. Balker, L. Serrano, and B. Lindner. Hypochlorite adulteration of urine causing decreased concentration of delta-9-THC-COOH by GC-MS. J. Anal. Toxicol. 18(2): 101-103 (1994).
28. S.L. Mikkelsen and K.O. Ash. Adulterants causing false negative results in illicit drug testing. Clin. Chem. 34(11): 2333-2336 (1998).
29. F.M. Urry, G. Komaromy-Hiller, B. Staley, D.K. Crockett, M. Kushnir, G. Nelson, and R. Struempler. Nitrite adulteration of workplace urine drug-testing specimens I. Sources and associated concentrations of nitrite in urine and distinction between natural sources and adulteration. J. Anal. Toxicol. 22: 89-95 (1998).
30. S.A. Lewis, Sr, L.A. Lewis, and A. Tuinman, Potassium nitrite reaction with 11-nor-delta9-tetrahydrocannabinol-9-carbozylic acid in urine in relation to the drug screening analysis. J. Forensic Sci. 44(5): 951-955 (1999).
31. S.J. Salamone, E. Bender, R.A. Hui, and S. Rosen. A non-cannabinoid immunogen used to elicit antibodies with broad cross-reactivity to cannabinoid metabolites. J. Forensic Sci. 43: 821-826 (1998).